Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$92.6M raised · US$3.5 a share · TD Cowen +4 Dealers: TD Cowen (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co. (co-lead), H.C. Wainwright & Co., Rodman & Renshaw LLC Use of proceeds: Fund clinical trials, preclinical studies, regulatory filings, manufacturing, companion diagnostic, pre-commercial activities, working capital and general purposes | Aug 18, 2026 |